{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:24:51Z","timestamp":1782894291116,"version":"3.54.5"},"reference-count":119,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,13]]},"DOI":"10.1093\/ajh\/hpy018","type":"journal-article","created":{"date-parts":[[2018,2,25]],"date-time":"2018-02-25T20:06:39Z","timestamp":1519589199000},"page":"522-531","source":"Crossref","is-referenced-by-count":12,"title":["Progress in the Management of Primary Aldosteronism"],"prefix":"10.1093","volume":"31","author":[{"given":"Ryo","family":"Morimoto","sequence":"first","affiliation":[{"name":"Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University Hospital, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Omata","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University Hospital, Sendai, Miyagi, Japan"},{"name":"Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan"},{"name":"Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadayoshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University Hospital, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitoshi","family":"Satoh","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University Hospital, Sendai, Miyagi, Japan"},{"name":"Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,8]]},"reference":[{"key":"key\n\t\t\t\t20180625083743_CIT0001","first-page":"3","article-title":"Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J Lab Clin Med"},{"key":"key\n\t\t\t\t20180625083743_CIT0002","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20180625083743_CIT0003","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"key\n\t\t\t\t20180625083743_CIT0004","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0005","doi-asserted-by":"crossref","first-page":"E773","DOI":"10.1503\/cmaj.161486","article-title":"Primary aldosteronism: a common cause of resistant hypertension","volume":"189","author":"Kline","year":"2017","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t20180625083743_CIT0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jc.2014-3663","article-title":"Update in primary aldosteronism","volume":"100","author":"Stowasser","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0007","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00424-014-1658-0","article-title":"Primary aldosteronism and salt","volume":"467","author":"Funder","year":"2014","journal-title":"Eur J Physiol"},{"key":"key\n\t\t\t\t20180625083743_CIT0008","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0009","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1530\/EJE-14-0537","article-title":"Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension","volume":"172","author":"Piaditis","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20180625083743_CIT0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0031-1295438","article-title":"Prevalence of primary aldosteronism in patient\u2019s cohorts and in population-based studies\u2013a review of the current literature","volume":"44","author":"Hannemann","year":"2012","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t20180625083743_CIT0011","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180625083743_CIT0012","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180625083743_CIT0013","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180625083743_CIT0014","doi-asserted-by":"crossref","first-page":"E537","DOI":"10.1210\/jc.2011-2874","article-title":"Pattern of adrenal hormonal secretion in patients with adrenal adenomas: the relevance of aldosterone in arterial hypertension","volume":"97","author":"Pappa","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/hr.2010.166","article-title":"Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects","volume":"34","author":"Ito","year":"2011","journal-title":"Hypertens Res"},{"key":"key\n\t\t\t\t20180625083743_CIT0016","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0017","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1097\/HJH.0b013e3283559a03","article-title":"Primary aldosteronism: evidence against a second epidemic","volume":"30","author":"Kaplan","year":"2012","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20180625083743_CIT0018","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/ajh\/hpt091","article-title":"Bimodal aldosterone distribution in low-renin hypertension","volume":"26","author":"Adlin","year":"2013","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20180625083743_CIT0019","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/HJH.0000000000000880","article-title":"Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism","volume":"34","author":"Burrello","year":"2016","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20180625083743_CIT0020","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1161\/HYPERTENSIONAHA.117.09078","article-title":"Rapid screening of primary aldosteronism by a novel chemiluminescent Immunoassay","volume":"70","author":"Morimoto","year":"2017","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180625083743_CIT0021","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1097\/HJH.0000000000000727","article-title":"Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays","volume":"33","author":"Manolopoulou","year":"2015","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20180625083743_CIT0022","article-title":"Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"key\n\t\t\t\t20180625083743_CIT0023","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/ajh\/hpt047","article-title":"The role of plasma renin activity, age, and race in selecting effective initial drug therapy for hypertension","volume":"26","author":"Schwartz","year":"2013","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20180625083743_CIT0024","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/HJH.0000000000000168","article-title":"Metabolomics in hypertension","volume":"32","author":"Nikolic","year":"2014","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20180625083743_CIT0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cca.2014.03.015","article-title":"Combination of LC-MS\/MS aldosterone and automated direct renin in screening for primary aldosteronism","volume":"433","author":"Juutilainen","year":"2014","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t20180625083743_CIT0026","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jsbmb.2014.10.006","article-title":"An LC-MS\/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism","volume":"145","author":"Peitzsch","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key\n\t\t\t\t20180625083743_CIT0027","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1373\/clinchem.2015.251199","article-title":"Mass spectrometry-B ased adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism","volume":"62","author":"Eisenhofer","year":"2016","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20180625083743_CIT0028","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2017.271106","article-title":"High-resolution, accurate-mass (hRAM) mass spectrometry urine steroid profiling in the diagnosis of adrenal disorders","author":"Hines","year":"2017; 63(12):1824\u20131835","journal-title":"Clinical chemistry"},{"key":"key\n\t\t\t\t20180625083743_CIT0029","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.beem.2013.05.011","article-title":"Heterophilic antibody interference in immunometric assays","volume":"27","author":"Bolstad","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0030","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1210\/jc.2011-2384","article-title":"18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes","volume":"97","author":"Mulatero","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0031","doi-asserted-by":"crossref","first-page":"E1272","DOI":"10.1210\/jc.2010-2785","article-title":"18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism","volume":"96","author":"Nakamura","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0032","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism","volume":"65","author":"Satoh","year":"2015","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180625083743_CIT0033","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20180625083743_CIT0034","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","article-title":"Pathologic features of prognostic significance in adrenocortical carcinoma","volume":"13","author":"Weiss","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20180625083743_CIT0035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12022-014-9307-x","article-title":"Aldosterone-secreting adrenal cortical carcinoma. A case report and review of the literature","volume":"25","author":"Griffin","year":"2014","journal-title":"Endocr Pathol"},{"key":"key\n\t\t\t\t20180625083743_CIT0036","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/jhh.2015.100","article-title":"A case of bilateral aldosterone-producing adenomas differentiated by segmental adrenal venous sampling for bilateral adrenal sparing surgery","volume":"30","author":"Morimoto","year":"2016","journal-title":"J Hum Hypertens"},{"key":"key\n\t\t\t\t20180625083743_CIT0037","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/ca.22374","article-title":"A review of the anatomy and clinical significance of adrenal veins","volume":"27","author":"Cesmebasi","year":"2014","journal-title":"Clin Anat"},{"key":"key\n\t\t\t\t20180625083743_CIT0038","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/HYPERTENSIONAHA.116.08375","article-title":"Anatomical variations of the right adrenal vein: concordance between multidetector computed tomography and catheter venography","volume":"69","author":"Omura","year":"2017","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180625083743_CIT0039","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1148\/radiol.2015142159","article-title":"Intra-adrenal aldosterone secretion: segmental adrenal venous sampling for localization","volume":"278","author":"Satani","year":"2016","journal-title":"Radiology"},{"key":"key\n\t\t\t\t20180625083743_CIT0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180625083743_CIT0041","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/ajh.2011.148","article-title":"Intraprocedural cortisol measurement increases adrenal vein sampling success rate in primary aldosteronism","volume":"24","author":"Rossi","year":"2011","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20180625083743_CIT0042","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-11-0287","article-title":"Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates","volume":"165","author":"Betz","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20180625083743_CIT0043","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1210\/jc.2016-1011","article-title":"Impact of new quick gold nanoparticle-based cortisol assay during adrenal vein sampling for primary aldosteronism","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0044","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s00270-013-0820-y","article-title":"Right adrenal venography findings correlated with C-arm CT for selection during C-arm CT-assisted adrenal vein sampling in primary aldosteronism","volume":"37","author":"Park","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"key\n\t\t\t\t20180625083743_CIT0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1530\/EJE-14-1161","article-title":"Is there a role for segmental adrenal venous sampling and adrenal sparing surgery in patients with primary aldosteronism","volume":"173","author":"Satoh","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20180625083743_CIT0046","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/HYPERTENSIONAHA.115.06305","article-title":"Clinical management and outcomes of adrenal hemorrhage following adrenal vein sampling in primary aldosteronism","volume":"67","author":"Monticone","year":"2016","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180625083743_CIT0047","first-page":"982","article-title":"In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors","volume":"39","author":"Bergstr\u00f6m","year":"1998","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20180625083743_CIT0048","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/jc.2011-1537","article-title":"Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn\u2019s adenomas","volume":"97","author":"Burton","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0049","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00259-004-1575-0","article-title":"Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate","volume":"31","author":"Zettinig","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t20180625083743_CIT0050","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00423-010-0681-7","article-title":"11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism","volume":"395","author":"Hennings","year":"2010","journal-title":"Langenbecks Arch Surg"},{"key":"key\n\t\t\t\t20180625083743_CIT0051","first-page":"275","article-title":"PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate","volume":"41","author":"Bergstr\u00f6m","year":"2000","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20180625083743_CIT0052","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1210\/jc.2005-2273","article-title":"[11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings","volume":"91","author":"Hennings","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0053","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180625083743_CIT0054","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.surg.2014.08.021","article-title":"Long-term blood pressure control in patients undergoing adrenalectomy for primary hyperaldosteronism","volume":"156","author":"Wachtel","year":"2014","journal-title":"Surgery"},{"key":"key\n\t\t\t\t20180625083743_CIT0055","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/1470320314549220","article-title":"Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism","volume":"16","author":"Indra","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"key\n\t\t\t\t20180625083743_CIT0056","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2011.12.003","article-title":"Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma","volume":"221","author":"Lin","year":"2012","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20180625083743_CIT0057","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.surg.2011.02.006","article-title":"Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy","volume":"150","author":"Lin","year":"2011","journal-title":"Surgery"},{"key":"key\n\t\t\t\t20180625083743_CIT0058","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1097\/HJH.0b013e3283550f93","article-title":"Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism","volume":"30","author":"Lin","year":"2012","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20180625083743_CIT0059","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/ajh\/hpu154","article-title":"Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies","volume":"28","author":"Marzano","year":"2015","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20180625083743_CIT0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1470320310376424","article-title":"Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy","volume":"12","author":"Lin","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"key\n\t\t\t\t20180625083743_CIT0061","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ajh.2010.169","article-title":"Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment","volume":"23","author":"Sechi","year":"2010","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20180625083743_CIT0062","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: The german Conn registry","volume":"60","year":"2012","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180625083743_CIT0063","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1210\/jc.2012-2234","article-title":"Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy","volume":"97","author":"Fischer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0064","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12902-016-0121-y","article-title":"Severe hyperkalemia following adrenalectomy for aldosteronoma: prediction, pathogenesis and approach to clinical management- a case series","volume":"16","author":"Tahir","year":"2016","journal-title":"BMC Endocr Disord"},{"key":"key\n\t\t\t\t20180625083743_CIT0065","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/j.ajkd.2009.06.014","article-title":"Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma","volume":"54","author":"Wu","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20180625083743_CIT0066","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/HYPERTENSIONAHA.115.05924","article-title":"Renal resistive index predicts postoperative blood pressure outcome in primary aldosteronism","volume":"67","author":"Iwakura","year":"2016","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180625083743_CIT0067","doi-asserted-by":"crossref","first-page":"e3930","DOI":"10.1097\/MD.0000000000003930","article-title":"Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism","volume":"95","author":"Kim","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t20180625083743_CIT0068","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jc.2013-2180","article-title":"Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases","volume":"99","author":"Iwakura","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0069","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2008-1851","article-title":"Risk factors associated with a low glomerular filtration rate in primary aldosteronism","volume":"94","author":"Reincke","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0070","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/SLA.0b013e318165c075","article-title":"The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma","volume":"247","author":"Zarnegar","year":"2008","journal-title":"Ann Surg"},{"key":"key\n\t\t\t\t20180625083743_CIT0071","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.amjsurg.2015.05.033","article-title":"Characteristics predicting clinical improvement and cure following laparoscopic adrenalectomy for primary aldosteronism in a large cohort","volume":"210","author":"Worth","year":"2015","journal-title":"Am J Surg"},{"key":"key\n\t\t\t\t20180625083743_CIT0072","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ajh.2008.175","article-title":"Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas","volume":"21","author":"Mourad","year":"2008","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20180625083743_CIT0073","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/bjs.9744","article-title":"Systematic review of surgery and outcomes in patients with primary aldosteronism","volume":"102","author":"Muth","year":"2015","journal-title":"Br J Surg"},{"key":"key\n\t\t\t\t20180625083743_CIT0074","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0031-1299681","article-title":"Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review","volume":"44","author":"Steichen","year":"2012","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t20180625083743_CIT0075","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: An international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"key\n\t\t\t\t20180625083743_CIT0076","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0034-1373797","article-title":"Image-guided ablation of adrenal lesions","volume":"31","author":"Yamakado","year":"2014","journal-title":"Semin Intervent Radiol"},{"key":"key\n\t\t\t\t20180625083743_CIT0077","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1053\/j.tvir.2013.08.008","article-title":"Image-guided ablation of adrenal tumors","volume":"16","author":"Ethier","year":"2013","journal-title":"Tech Vasc Interv Radiol"},{"key":"key\n\t\t\t\t20180625083743_CIT0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvir.2016.12.791","article-title":"Local control and survival after image-guided percutaneous ablation of adrenal metastases","author":"Frenk","year":"2017;29(2):276\u2013284","journal-title":"J Vasc Interv Radiol"},{"key":"key\n\t\t\t\t20180625083743_CIT0079","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ctrv.2014.04.001","article-title":"Surgical and ablative therapies for the management of adrenal \u2018oligometastases\u2019 - A systematic review","volume":"40","author":"Gunjur","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"key\n\t\t\t\t20180625083743_CIT0080","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1089\/end.2013.0635","article-title":"Retroperitoneoscopic-guided cool-tip radiofrequency ablation of adrenocortical aldosteronoma","volume":"28","author":"Yang","year":"2014","journal-title":"J Endourol"},{"key":"key\n\t\t\t\t20180625083743_CIT0081","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/radiol.2016152277","article-title":"Aldosterone-producing adenoma in primary aldosteronism: CT-guided radiofrequency ablation-long-term results and recurrence rate","volume":"281","author":"Liu","year":"2016","journal-title":"Radiology"},{"key":"key\n\t\t\t\t20180625083743_CIT0082","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/SLA.0b013e318f66936","article-title":"Radiofrequency ablation for benign aldosterone-producing adenoma: a scarless technique to an old disease","volume":"252","author":"Liu","year":"2010","journal-title":"Ann Surg"},{"key":"key\n\t\t\t\t20180625083743_CIT0083","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jvir.2016.03.042","article-title":"Clinical outcomes following percutaneous radiofrequency ablation of unilateral aldosterone-producing adenoma: comparison with adrenalectomy","volume":"27","author":"Sarwar","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"key\n\t\t\t\t20180625083743_CIT0084","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejphar.2015.06.015","article-title":"Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist","volume":"761","author":"Arai","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t20180625083743_CIT0085","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1124\/jpet.116.234765","article-title":"CS-3150, a novel nonsteroidal mineralocorticoid receptor antagonist, shows preventive and therapeutic effects on renal injury in deoxycorticosterone acetate\/salt-induced hypertensive rats","volume":"358","author":"Arai","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20180625083743_CIT0086","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejphar.2015.11.028","article-title":"CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats","volume":"769","author":"Arai","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t20180625083743_CIT0087","doi-asserted-by":"crossref","first-page":"T125","DOI":"10.1530\/JOE-16-0600","article-title":"Mineralocorticoid receptor antagonists: 60 years of research and development","volume":"234","author":"Kolkhof","year":"2017","journal-title":"J. Endocrinol"},{"key":"key\n\t\t\t\t20180625083743_CIT0088","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11906-016-0649-2","article-title":"Finerenone: a new mineralocorticoid receptor antagonist without hyperkalemia: an opportunity in patients with CKD","volume":"18","author":"Haller","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"key\n\t\t\t\t20180625083743_CIT0089","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coph.2016.02.005","article-title":"Mineralocorticoid receptor antagonists-pharmacodynamics and pharmacokinetic differences","volume":"27","author":"Yang","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"key\n\t\t\t\t20180625083743_CIT0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/FJC.0000000000000329","article-title":"Third-generation mineralocorticoid receptor antagonists: why do we need a fourth","volume":"67","author":"Gomez-Sanchez","year":"2016","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t20180625083743_CIT0091","first-page":"271","article-title":"Steroidal and novel non-steroidal mineralocorticoid receptor antagonists in heart failure and cardiorenal diseases: comparison at bench and bedside","volume-title":"Handbook of Experimental Pharmacology","author":"Kolkhof","year":"2017"},{"key":"key\n\t\t\t\t20180625083743_CIT0092","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jama.2015.10081","article-title":"Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial","volume":"314","author":"Bakris","year":"2015","journal-title":"J Am Podiatr Med Assoc"},{"key":"key\n\t\t\t\t20180625083743_CIT0093","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/eurheartj\/ehw132","article-title":"A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and\/or chronic kidney disease","volume":"37","author":"Filippatos","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180625083743_CIT0094","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.111.029892","article-title":"Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial","volume":"124","author":"Calhoun","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180625083743_CIT0095","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/HYPERTENSIONAHA.110.157271","article-title":"Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism","volume":"56","author":"Amar","year":"2010","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180625083743_CIT0096","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1751-7176.2012.00667.x","article-title":"The effects of aldosterone synthase inhibition on aldosterone and cortisol in patients with hypertension: a phase II, randomized, double-blind, placebo-controlled, multicenter study","volume":"14","author":"Andersen","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"key\n\t\t\t\t20180625083743_CIT0097","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/HJH.0b013e328363570c","article-title":"Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy","volume":"31","author":"Schumacher","year":"2013","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20180625083743_CIT0098","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/HJH.0b013e32835d6d49","article-title":"Sequential comparison of aldosterone synthase inhibition and mineralocorticoid blockade in patients with primary aldosteronism","volume":"31","author":"Amar","year":"2013","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20180625083743_CIT0099","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1470320317717883","article-title":"LY3045697: Results from two randomized clinical trials of a novel inhibitor of aldosterone synthase","volume":"18","author":"Sloan-Lancaster","year":"2017","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"key\n\t\t\t\t20180625083743_CIT0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/HYPERTENSIONAHA.116.07716","article-title":"Preclinical and early clinical profile of a highly selective and potent oral inhibitor of aldosterone synthase (CYP11B2)","volume":"69","author":"Bogman","year":"2017","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180625083743_CIT0101","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1530\/JME-17-0035","article-title":"Somatic and inherited mutations in primary aldosteronism","volume":"59","author":"Fernandes-Rosa","year":"2017","journal-title":"J Mol Endocrinol"},{"key":"key\n\t\t\t\t20180625083743_CIT0102","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in aTP1A1 and cACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nature Genetics"},{"key":"key\n\t\t\t\t20180625083743_CIT0103","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline cACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat. Genet"},{"key":"key\n\t\t\t\t20180625083743_CIT0104","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in aTP1A1 and aTP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Boulkroun","year":"2013","journal-title":"Nat. Genet"},{"key":"key\n\t\t\t\t20180625083743_CIT0105","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"key\n\t\t\t\t20180625083743_CIT0106","doi-asserted-by":"crossref","first-page":"E1567","DOI":"10.1210\/jc.2011-3132","article-title":"Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells","volume":"97","author":"Monticone","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0107","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1210\/en.2012-1241","article-title":"The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line","volume":"153","author":"Oki","year":"2012","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20180625083743_CIT0108","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5551\/jat.24455","article-title":"Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas","volume":"22","author":"Kitamoto","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"key\n\t\t\t\t20180625083743_CIT0109","doi-asserted-by":"crossref","first-page":"11396","DOI":"10.1038\/srep11396","article-title":"Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population","volume":"5","author":"Wu","year":"2015","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20180625083743_CIT0110","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/cen.12873","article-title":"Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype","volume":"83","author":"Scholl","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t20180625083743_CIT0111","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.1038\/srep19546","article-title":"Activating mutations in CTNNB1 in aldosterone producing adenomas","volume":"6","author":"\u00c5kerstr\u00f6m","year":"2016","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20180625083743_CIT0112","doi-asserted-by":"crossref","first-page":"e0147590","DOI":"10.1371\/journal.pone.0147590","article-title":"Genetics of aldosterone-producing adenoma in Korean patients","volume":"11","author":"Hong","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180625083743_CIT0113","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma","volume":"65","author":"Zheng","year":"2015","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180625083743_CIT0114","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180625083743_CIT0115","first-page":"1182","article-title":"Histopathological classification of cross-sectional image-negative hyperaldosteronism","volume":"102","author":"Yamazaki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0116","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/js.2017-00134","article-title":"Aldosterone-producing cell clusters frequently harbor somatic mutations and accumulate with age in normal adrenals","volume":"1","author":"Omata","year":"2017","journal-title":"J Endocr Soc"},{"key":"key\n\t\t\t\t20180625083743_CIT0117","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.mce.2016.10.014","article-title":"Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism","volume":"441","author":"Nishimoto","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"key\n\t\t\t\t20180625083743_CIT0118","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1210\/jc.2015-3285","article-title":"Case report: nodule development from subcapsular aldosterone-producing cell clusters causes hyperaldosteronism","volume":"101","author":"Nishimoto","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180625083743_CIT0119","doi-asserted-by":"crossref","first-page":"7834356","DOI":"10.1155\/2016\/7834356","article-title":"Human adrenocortical remodeling leading to aldosterone-producing cell cluster generation","volume":"2016","author":"Nishimoto","year":"2016","journal-title":"Int J Endocrinol"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajh\/article-pdf\/31\/5\/522\/25082250\/hpy018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T20:34:37Z","timestamp":1570826077000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/31\/5\/522\/4925157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,8]]},"references-count":119,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,3,8]]},"published-print":{"date-parts":[[2018,4,13]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpy018","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,3,8]]}}}